mRNA access
Scope
Date
~
-
Bio & Pharma
Lemonex signs MOU with WHO mRNA vaccines tech hub
South Korea's gene therapeutics developer Lemonex announced on Tuesday that it has signed a memorandum of understanding (MOU) with the World Health ...
May 09, 2023 (Gmt+09:00)
-
Artificial intelligence
Wrtn to offer free access GPT-4 conversation services
South Korean generative AI startup Wrtn Technologies announced on Thursday that it will offer unlimited free access to its conversation feature...
May 04, 2023 (Gmt+09:00)
-
Korean SMEs
S.Korea’s Suprema wins order from Saudi Arabia's Neom city project
South Korea’s Suprema Inc., an artificial intelligence (AI)-based security company, on Wednesday said it won a large-scale project in Neom, a ...
May 04, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
POSCO, three telcos to build communication systems against disasters
South Korean steel giant POSCO said on Friday that it has signed a memorandum of understanding (MOU) with three domestic telecommunications companie...
Apr 21, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
S.Korea's S-1 releases facial recognition reader 2.0
South Korea's system securities provider S-1 Corp. has launched a new solution that reduces the facial recognition time by 40% compared to previous ...
Apr 03, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
CJ OliveNetworks launches API marketplace platform API Plex
CJ OliveNetworks, an ICT subsidiary of South Korea's CJ Group, said on Tuesday that it has launched an application programming interface (API) marke...
Mar 29, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
Mar 09, 2023 (Gmt+09:00)
-
Robotics
LG Elec places GuideBot in museums to improve viewing accessibility
LG Electronics Inc. announced on Thursday that the LG CLOi GuideBot "Qi" will be deployed as a curator at both the Gongju National Museum and Nation...
Feb 16, 2023 (Gmt+09:00)
-
Robotics
Hyundai Elevator's open API sees rapid expansion of participants
Hyundai Elevator Group announced on Tuesday that its open API (application programming interface), which was launched in March last year, has seen r...
Feb 14, 2023 (Gmt+09:00)
-
Korean Innovators at CES 2023
Muzlive showcases KiT albums of Blackpink, Jason Mraz
LAS VEGAS – South Korean media platform startup Muzlive Inc. showcased KiTs of K-pop girl group Blackpink, singer-songwriter Jason Mraz and ot...
Jan 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong, Onchorus to undertake research on mRNA anticancer drugs
Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Moderna to stay ahead in mRNA technology: CSO Melissa Moore
CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...
Oct 14, 2022 (Gmt+09:00)
-
Entertainment
TVing partners with Paramount Plus to challenge Netflix in Korea
South Korea's over-the-top streaming platform TVing Co. has partnered with global content provider Paramount Plus to challenge top OTT player Netfli...
Jun 17, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector
SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...
Mar 31, 2022 (Gmt+09:00)
-
Healthcare
LG Elec. targets North American digital healthcare market
South Korea’s LG Electronics Inc. has made inroads into the North American digital healthcare market with US telehealth company Amwell as the ...
Mar 21, 2022 (Gmt+09:00)
language -
War in Ukraine
Korean shipbuilders see material impact from sanctions on Russia
International sanctions on Russia over its invasion of Ukraine are set to have a material impact on South Korea’s three largest shipbuilders, ...
Mar 13, 2022 (Gmt+09:00)
-
Biotech
Celltrion looks beyond biosimilars to develop its own mRNA drugs
South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...
Nov 16, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics-made Moderna vaccine available to Koreans this week
Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...
Oct 27, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
COVID-19
Korean govt to spend $1.9 billion to become world’s leading vaccine maker
The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
War for bio talent intensifies as S.Korea works on mRNA vaccines
As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
COVID treatment deals drive Samsung Bio’s record quarterly earnings
South Korea’s Samsung Biologics Co. posted its highest quarterly revenue and operating profit, thanks largely to a number of long-term manufac...
Jul 28, 2021 (Gmt+09:00)
-
COVID-19
Eyegene to kick off Korea’s first mRNA clinical trial
Eyegene Inc. will be South Korea’s first vaccine maker to conduct clinical tests of messenger ribonucleic acid (mRNA) COVID-19 vaccines. Ealie...
Jul 01, 2021 (Gmt+09:00)
-
COVID-19
Korea’s pharma consortium to develop mRNA vaccines by 2022
South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...
Jun 30, 2021 (Gmt+09:00)
language -
COVID-19 vaccines
Samsung Bio plans to manufacture mRNA drug substance from 2022
Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...
May 31, 2021 (Gmt+09:00)
language -
COVID-19
Samsung Biologics to make Moderna’s mRNA vaccine from Q3
Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...
May 23, 2021 (Gmt+09:00)
language
Latest News
- 1 Maybe Happy Ending: How a Seoul-made robot love story rewrote Broadway playbook
- 2 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 3 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 4 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 5 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs